Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
The American Journal of Surgical Pathology
|
April 14, 2012
TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients
William R Sukov, Jennelle C Hodge, Christine M Lohse, et al.
American Journal of Clinical Pathology
|
January 29, 2013
Comparison of fluorescence in situ hybridization (FISH) and dual-ISH (DISH) in the determination of HER2 status in breast cancer
Aaron S Mansfield, William R Sukov, Jeanette E Eckel-Passow, et al.
Cancer
|
October 24, 2013
HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma
Harry H Yoon, William R Sukov, Qian Shi, et al.
American Journal of Clinical Pathology
|
June 30, 2016
Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization: Defining an Effective Utilization Strategy for Evaluation of Myelodysplastic Syndromes
Rong He, Anne E Wiktor, David K Durnick, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 9, 2011
Section E9 of the American College of Medical Genetics technical standards and guidelines: fluorescence in situ hybridization
James T Mascarello, Betsy Hirsch, Hutton M Kearney, et al.
International Journal of Cancer
|
May 21, 2016
Central nervous system relapse in patients with untreated HER2-positive esophageal or gastroesophageal junction adenocarcinoma
Harry H Yoon, Mark A Lewis, Nathan R Foster, et al.
Cancer Genetics and Cytogenetics
|
September 30, 2010
Nearly identical near-haploid karyotype in a peritoneal mesothelioma and a retroperitoneal malignant peripheral nerve sheath tumor
William R Sukov, Rhett P Ketterling, Sainan Wei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2012
Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinoma
Harry H Yoon, Qian Shi, William R Sukov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 27, 2016
Change in Pattern of HER2 Fluorescent in Situ Hybridization (FISH) Results in Breast Cancers Submitted for FISH Testing: Experience of a Reference Laboratory Using US Food and Drug Administration Criteria and American Society of Clinical Oncology and College of American Pathologists Guidelines
Mithun Vinod Shah, Anne E Wiktor, Reid G Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 19, 2012
Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas
Harry H Yoon, Qian Shi, William R Sukov, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
The American Journal of Surgical Pathology
|
April 14, 2012
TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients
William R Sukov, Jennelle C Hodge, Christine M Lohse, et al.
American Journal of Clinical Pathology
|
January 29, 2013
Comparison of fluorescence in situ hybridization (FISH) and dual-ISH (DISH) in the determination of HER2 status in breast cancer
Aaron S Mansfield, William R Sukov, Jeanette E Eckel-Passow, et al.
Cancer
|
October 24, 2013
HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma
Harry H Yoon, William R Sukov, Qian Shi, et al.
American Journal of Clinical Pathology
|
June 30, 2016
Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization: Defining an Effective Utilization Strategy for Evaluation of Myelodysplastic Syndromes
Rong He, Anne E Wiktor, David K Durnick, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 9, 2011
Section E9 of the American College of Medical Genetics technical standards and guidelines: fluorescence in situ hybridization
James T Mascarello, Betsy Hirsch, Hutton M Kearney, et al.
International Journal of Cancer
|
May 21, 2016
Central nervous system relapse in patients with untreated HER2-positive esophageal or gastroesophageal junction adenocarcinoma
Harry H Yoon, Mark A Lewis, Nathan R Foster, et al.
Cancer Genetics and Cytogenetics
|
September 30, 2010
Nearly identical near-haploid karyotype in a peritoneal mesothelioma and a retroperitoneal malignant peripheral nerve sheath tumor
William R Sukov, Rhett P Ketterling, Sainan Wei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2012
Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinoma
Harry H Yoon, Qian Shi, William R Sukov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 27, 2016
Change in Pattern of HER2 Fluorescent in Situ Hybridization (FISH) Results in Breast Cancers Submitted for FISH Testing: Experience of a Reference Laboratory Using US Food and Drug Administration Criteria and American Society of Clinical Oncology and College of American Pathologists Guidelines
Mithun Vinod Shah, Anne E Wiktor, Reid G Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 19, 2012
Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas
Harry H Yoon, Qian Shi, William R Sukov, et al.
Page
of 3